HIGH IMPACT FOR THE PATIENT

CRM Therapeutics develops and exploits a platform technology which substantially improves intracellular drug-delivery. By combining its patented targeted delivery method with existing proven pharmaceutical compounds, CRM Therapeutics expects to improve efficacy of disease treatment dramatically in combination with the decrease of side-effects while requiring

a substially smaller dosing.